No photo of Hilma van der Horst

Hilma van der Horst

MSC.

20192019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2019 2019

CD20 and CD37 antibodies synergize to activate complement by Fc-mediated clustering

Oostindie, S. C., van der Horst, H. J., Lindorfer, M. A., Cook, E. M., Tupitza, J. C., Zent, C. S., Burack, R., VanDerMeid, K. R., Strumane, K., Chamuleau, M. E. D., Mutis, T., de Jong, R. N., Schuurman, J., Breij, E. C. W., Beurskens, F. J., Parren, P. W. H. I. & Taylor, R. P., 21 Feb 2019, In : Haematologica.

Research output: Contribution to journalArticleAcademicpeer-review

Preclinical evidence for an effective therapeutic activity of FL118, a novel survivin inhibitor, in patients with relapsed/refractory multiple myeloma

Holthof, L. C., van der Horst, H. J., van Hal-van Veen, S. E., Ruiter, R. W. J., Li, F., Buijze, M., Andersen, M. N., Yuan, H., de Bruijn, J., van de Donk, N. W. C. J., Lokhorst, H. M., Zweegman, S., Groen, R. W. J. & Mutis, T., 23 May 2019, In : Haematologica.

Research output: Contribution to journalArticleAcademicpeer-review